Anti-angiogenesis effect of trichosanthin and the underlying mechanism

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 735-740

  He, Dongxu ^a   Jin, Jian ^a   Zheng, Yongtang ^b   Bruce, Iain C ^c   Tam, Siucheung ^d   Ma, Xin ^a  

^a JIANGNAN UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Extracellular signal regulated kinases; Trichosanthin; Tumor angiogenesis; Vascular endothelial growth factor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; TRICHOSANTHIN; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD VESSEL; CANCER GROWTH; CANCER INHIBITION; CELL MIGRATION; CELL MOTILITY; CHORIOCARCINOMA; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR RING; WOUND HEALING;

RATTUS;

EID: 84872345551     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.080     Document Type: Article

References (18)

1. Fiorio P.A., Ong H.L., Cheng K.T., Brossa A., Bussolati B., Lockwich T., Paria B., Munaron L., Ambudkar I.S. TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling. Oncogene 2011.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1995, 1:27-31.
3. Papetti M., Herman I.M. Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol. 2002, 282:C947-C970.
4. Leung K.N., Yeung H.W., Leung S.O. The immunomodulatory and antitumor activities of trichosanthin-an abortifacient protein isolated from tian-hua-fen (Trichosanthes kirilowii). Asian Pac. J.Allergy Immunol. 1986, 4:111-120.
5. Zhao J., Ben L.H., Wu Y.L., Hu W., Ling H., Xin S.M., Nie H.L., Ma L., Pei G. Anti-HIV agent trichosanthin enhances the capabilities of chemokines to stimulate chemotaxis and G protein activation and this is mediated through interaction of trichosanthin and chemokine receptors. J. Exp. Med. 1999, 190:101-111. 5-7-1999.
6. Dalgleish A.G., O'Byrne K. Inflammation and cancer: the role of the immune response and angiogenesis. Cancer Treat. Res. 2006, 130:1-38.
7. Kurebayashi J., Otsuki T., Kunisue H., Mikami Y., Tanaka K., Yamamoto S., Sonoo H. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn. J. Cancer Res. 1999, 90:977-981.
8. Aplin A.C., Fogel E., Zorzi P., Nicosia R.F. The aortic ring model of angiogenesis. Methods Enzymol. 2008, 443:119-136.
9. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
10. Shaw P.C., Lee K.M., Wong K.B. Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties. Toxicon 2005, 45:683-689.
11. Xu W.F., Ji Y.Y., Wu Y.D., Lin G.M., Ye M., Sun B. Roles of IL-4 and other factors in the trichosanthin-induced ovalbumin-specific IgE response. Acta Pharmacol. Sin. 2001, 22:736-740.
12. Connolly D.T., Heuvelman D.M., Nelson R., Olander J.V., Eppley B.L., Delfino J.J., Siegel N.R., Leimgruber R.M., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 1989, 84:1470-1478.
13. Gliki G., Abu-Ghazaleh R., Jezequel S., Wheeler-Jones C., Zachary I. Vascular endothelial growth factor-induced prostacyclin production is mediated by a protein kinase C (PKC)-dependent activation of extracellular signal-regulated protein kinases 1 and 2 involving PKC-delta and by mobilization of intracellular Ca2+. Biochem. J. 2001, 353:503-512.
14. Breslin J.W., Pappas P.J., Cerveira J.J., Hobson R.W., Duran W.N. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H92-H100.
15. Bancroft C.C., Chen Z., Dong G., Sunwoo J.B., Yeh N., Park C., Van W.C. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin. Cancer Res. 2001, 7:435-442.
16. Niu G., Wright K.L., Huang M., Song L., Haura E., Turkson J., Zhang S., Wang T., Sinibaldi D., Coppola D., Heller R., Ellis L.M., Karras J., Bromberg J., Pardoll D., Jove R., Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008.
17. Goldman C.K., Kim J., Wong W.L., King V., Brock T., Gillespie G.Y. Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell 1993, 4:121-133.
18. Huang H., Chan H., Wang Y.Y., Ouyang D.Y., Zheng Y.T., Tam S.C. Trichosanthin suppresses the elevation of p38 MAPK, and Bcl-2 induced by HSV-1 infection in Vero cells. Life Sci. 2006, 79:1287-1292.